News for Oscotec Inc. (039200.KQ)

Published at

Dec 21, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Autoimmune Diseases Diagnostics Global Market to Surpass 6 Billion Mark by 2028 | DelveInsight

The increasing prevalence of autoimmune disorders, including conditions like Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease, is a key driver...

SUNPHARMA.NS CPHRF CPH.TO 039200.KQ XGN SUNPHARMA-BL.NS MYMD LLY.MX LLY.DE LLY.BA LLY LILY34.SA GXE.DE GRFS GRFPN.MX GRF.MC GLPGF GLPG.AS GLPG GILDD.BA GIKLY GIFOF GIFLF BBI ABTCL.SN ABT.SN ABT 0Q1G.L 003520.KS LH.MX LH L1CA34.SA HMGN DSRLF DIA.MI ABCZF ABCM ABC.L 0JSY.L

Read more →
Published at

Oct 10, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Musculoskeletal Pain Market Set to Observe Remunerative Growth During the Study Period (2019-2032) | DelveInsight

The emergence of new products in the pipeline will add to the musculoskeletal pain market growth in the future. In addition, persistently rising cases of...

CPHRF CPH.TO 039200.KQ MYMD GXE.DE GLPGF GLPG.AS GLPG GILDD.BA BBI 4548.T 003520.KS SUNPHARMA-BL.NS LLY.MX LLY.DE LLY.BA LLY LILY34.SA 0Q1G.L

Read more →
Published at

Sep 21, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Sjogren's Syndrome Market Size Increase with Significant CAGR by 2032, Predicts DelveInsight | Key Companies in the Market - Resolve, MorphoSys, Novartis, GlaxoSmithKline, Roche, BMS, TearSolutions, I

Sjogren's syndrome market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness...

LLY.MX LLY.DE LLY.BA LLY LILY34.SA INCY I1NC34.SA GXE.DE GLPGF GLPG.AS GLPG GILDD.BA CPHRF CPH.TO 0Q1G.L 0J9P.L 039200.KQ NKTR MYMD BIOCON.NS BIOCON.BO BBI 0UNL.L 003520.KS

Read more →
Published at

Jul 6, 2023 7:00 PM

by globenewswire.com

mixed

mixed

Anti-Inflammatory Drugs Global Market to Accelerate at a CAGR of ~6% by 2028 | DelveInsight

The growing frequency of chronic diseases such as asthma, arthritis, chronic obstructive pulmonary disease (COPD), and others is driving up demand for...

UCBJY UCBJF SUNPHARMA-BL.NS SNCPF PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA JNJ GLAXF DJNJ3.BA DJNJ2.BA CPHRF CPH.TO AMGN.MX AMGN.BA AMGN AMG.DE 600276.SS 0K9E.L 039200.KQ STAR.NS STAR.BO SNNAQ SILO RKT.L RBN.MX RBGPF RBGLY RB.L MYMD MRKD.BA MRK.SN MRK.PA MRK.MX MRK MEOBF LLY.MX LLY.DE LLY.BA LLY LILY34.SA IVBXF GXE.DE GLPGF GLPG.AS GLPG GILDD.BA FRPRF CTAGY CTAGF BRM.DE BONS.TA BMYB34.SA BMY.MX BMY.BA BMY BBIXF BBI AZNCF ASZP ABBV34.SA ABBV.MX ABBV.BA ABBV 6MK.DE 4AB.DE 3RB.DE 0Q1G.L 003520.KS HRTX 0J4V.L

Read more →
Published at

Apr 4, 2023 9:20 AM

by prnewswire.com

positive

positive

Beactica Therapeutics and Oscotec mutually agree to conclude oncology collaboration

/PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision oncology company, and Oscotec Inc. (039200: KOSDAQ), the Korean drug development company, today...

039200.KQ

Read more →
Published at

Feb 24, 2023 3:00 PM

by prnewswire.com

positive

positive

Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib

/PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidoplenib (SYK inhibitor) in...

039200.KQ

Read more →
Published at

Jul 26, 2022 5:30 PM

by prnewswire.com

mixed

mixed

New Therapeutics Options in Rheumatoid Arthritis Pipeline as 120+ Key Companies are Working on Drug Profiles | DelveInsight

/PRNewswire/ -- DelveInsight's 'Rheumatoid Arthritis Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

IDP.DE CPHRF CPH.TO BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB 688177.SS 039200.KQ MYMD LLY.MX LLY.DE LLY.BA LLY LILY34.SA LBPSW LBPS LABP GXE.DE GLPGF GLPG.AS GLPG GILDD.BA FRPRF DDDD.L BBI 0Q1G.L 003520.KS

Read more →